The relationship between phytoestrogen-rich supplements and breast cancer: A multicenter case–control study in Saudi Arabia

Authors

  • Sahar M. Alnefaie MD, MHPE, Asst. Prof., Department of Surgery, Taif University, Taif, Saudi Arabia.
  • Nawaf M. Alwagdani MBBS, Department of Orthopedic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Rashed A. Althobaiti MBBS, Department of General Surgery, Alhada Hospital for Armed Forces, Taif, Saudi Arabia.
  • Khaled M. Almansori MBBS, Department of General Surgery, Alhada Hospital for Armed Forces, Taif, Saudi Arabia.
  • Yousef Alalawi MD, FACS, Department of General Surgery, King Salman Hospital for Armed Forces, Tabuk, Saudi Arabia.
  • Eyad I. Al-Kharashi Breast and Endocrine Surgery, Department of General Surgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Ahmed Al-Ameer MD, FACS, Asst. Prof., Department of General Surgery, King Abdullah Hospital, Bisha, Saudi Arabia.
  • Maha Abdel Hadi MD, Prof., Department of Surgery, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Keywords:

Breast Cancer, Echinacea, Green Tea, Licorice Root, Soy isoflavones

Abstract

Objectives: The prospective effect of phytoestrogen-rich supplements has been explored by many researchers in an attempt to reduce breast cancer (BC) risk worldwide. In Saudi Arabia, some widely used supplements have high phytoestrogen content. Therefore, we aimed to (1) assess the relationship between phytoestrogen supplements (PSs) that are widely used among women of Saudi Arabia and BC and (2) assess the relationship based on the menstrual status.

Methods: The study took place during 2020–2022 to assess several PSs using a case–control design that included five centers from different provinces around the country. A questionnaire was answered by the participants that included 381 (46%) cases (diagnosed with BC) and 449 (54%) controls (free of BC). The PS items were assessed individually and on the multivariant analysis model.

Results: Of the 12 phytoestrogen-rich supplements, soy milk showed a significant decrease in BC risk. However, Echinacea showed an increased risk of BC among its users. A subgroup analysis based on the menstrual status demonstrated an increased risk of BC among licorice root and green tea users on premenopausal and postmenopausal women, respectively.

Conclusion: Soy isoflavones continue to show a significant risk reduction that could be used for a modified approach to reduce the risk of BC. However, Echinacea, licorice root, and green tea have shown to increase the risk of BC.

Downloads

Published

2024-09-08

How to Cite

Alnefaie, S. M., Alwagdani, N. M., Althobaiti, R. A., Almansori, K. M., Alalawi, Y., Al-Kharashi, E. I., Al-Ameer, A., & Abdel Hadi, M. (2024). The relationship between phytoestrogen-rich supplements and breast cancer: A multicenter case–control study in Saudi Arabia. International Journal of Health Sciences, 18(5), 35–42. Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/8548

Issue

Section

Original Paper